Only three months after banking an eye-popping $350 million series D round, Eikon Therapeutics is blaming government funding ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

The grant, which would have benefitted the Birmingham Biotechnology Hub, led by Southern Research, has been cancelled. The ...

Chicago’s life sciences market is the smallest of any major U.S. market by square footage yet has a vacancy rate of 43.3 ...

New York has added $10 million to its NYFIRST program to attract top research talent and boost biotech innovation, among ...

A new strain, named Niallia tiangongensis, has been identified on the Chinese space station Tiangong. This discovery was made ...

A biotech company has announced plans to acquire 23andMe after the genetic testing company filed for Chapter 11 bankruptcy.

Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...

A biotech research and development center announced that they have plans to set up operations in Spartanburg County.